Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway

Vaccine. 2023 Jan 9;41(2):614-620. doi: 10.1016/j.vaccine.2022.11.068. Epub 2022 Dec 2.

Authors

Ida Henriette Caspersen¹, Lene K Juvet², Berit Feiring², Ida Laake², Anna Hayman Robertson², Siri Mjaaland², Per Magnus³, Lill Trogstad²

Affiliations

¹ Centre for Fertility and Health, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway. Electronic address: ida.henriette.caspersen@fhi.no.
² Division of Infection Control, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.
³ Centre for Fertility and Health, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
BNT162 Vaccine*
COVID-19 Vaccines
COVID-19* / prevention & control
Child
Cohort Studies
Female
Humans
Menstruation Disturbances

Substances

BNT162 Vaccine
COVID-19 Vaccines